Presenter Biography

Christine Kay, M.D.

University of Florida

Dr. Kay is an assistant professor at the University of Florida and a vitreoretinal specialist in the Department of Ophthalmology. She completed her medical degree at the University of Florida, College of Medicine in 2005. After completing a transitional internship at the Roanoke Carilion Memorial Hospital, she completed her ophthalmology residency training at the University of South Florida, and a vitreoretinal fellowship at the University of Iowa. Her research currently focuses on the development and optimization of a viral vector delivery system for the genetic treatment of Achromotopsia. Specifically, her academic focus involves gene therapy research, evaluation of efficacy of vector therapy with electrophysiology, fundus imaging, optical coherence tomography, and immunohistochemistry. She is also interested in clinical studies regarding natural course of disease and electrophysiologic findings in patients with various inherited retinal diseases.

Meet our other presenters:

Keynote Speaker

• Michael Hingson, The Michael Hingson Group, Inc.

Presenters

• Isabelle Audo, M.D., PH.D., Quinze-Vingts Hospital
• Benjamin Bakall, Ph.D., University of Iowa
• William Beltran, D.V.M., Ph.D., School of Veterinary Medicine
• Eliot Berson, Massachusetts Eye and Ear Infirmary
• Kathy Blake
• Shannon Boye, University of Florida
• Rusty Bromley, Translational Research Acceleration via Consulting
• Tiffany Chan, O.D., Wilmer Eye Institute, Johns Hopkins University
• Charlie Collins, Vision Dynamics, LLC
• Stephen Daiger, University of Texas Health Science Center in Houston
• Arlene Drack
• Jacque L. Duncan, M.D., University of California, San Francisco
• Timothy Elder, TRE Legal Practice, LLC
• Gerald Fishman, M.D., The Chicago Lighthouse for People Who are Blind or Visually Impaired
• David M. Gamm, M.D., Ph.D., University of Wisconsin-Madison
• Duane R. Geruschat, Ph.D., Salus University
• Douglas Goist, National Industries for the Blind
• Michael Grassi
• James T. Handa, M.D., Wilmer Eye Institute, Johns Hopkins University
• Rod Haneline, Leader Dogs for the Blind
• Brian Hurley, National Industries for the Blind
• Christine Kay, M.D., University of Florida
• Mark E. Kleinman, M.D.
• Craig MacFarlane, Edward Jones Company
• Toni March, Office of Blindness and Vision Services, Division of Rehabilitation Services
• Michel Michaelides
• Muna Naash
• Mark Pennesi, M.D., Ph.D., Casey Eye Institute
• Darlene Peregoy, Office for Blindness and Vision Services, Division of Rehabilitation Services
• Eric Pierce, Massachusetts Eye and Ear Infirmary
• Dan Roberts, Macular Degeneration Support
• José-Alain Sahel, M.D.
• Philip Saunders
• Hendrik Scholl
• Everett T. Shupe II, MBA, CAE, CMP, Shupe Plans
• Janet Sunness, M.D., Hoover Low Vision Rehabilitation Services, Greater Baltimore Medical Center
• Karmen M Trzupek, MS, CGC, Informed Medical Decisions, Inc.
• Dawn E. Turco, Hadley School for the Blind
• Lou Tutt, Association for Education and Rehabilitation of the Blind and Visually Impaired
• Luk H. Vandenberghe, Ph.D., HMassachusetts Eye and Ear Infirmary and Harvard Medical School
• Douglas Walker, Hadley School for the Blind
• Richard G. Weleber, M.D., Casey Eye Institute, Oregon Health and Science University
• Dan Wenzel, Blind Industries and Services of Maryland
• Kim Walker, Tennessee School for the Blind
• Sandy White, Blind Sports Organization
• Paul Yang, M.D., Ph.D., University of Utah
• Donald Zack
• Michael Zuber